DK0703781T3 - Anvendelse af Efaroxan og derivater deraf til fremstilling af et lægemiddel til behandling af Parkinsons sygdom - Google Patents

Anvendelse af Efaroxan og derivater deraf til fremstilling af et lægemiddel til behandling af Parkinsons sygdom

Info

Publication number
DK0703781T3
DK0703781T3 DK94919712T DK94919712T DK0703781T3 DK 0703781 T3 DK0703781 T3 DK 0703781T3 DK 94919712 T DK94919712 T DK 94919712T DK 94919712 T DK94919712 T DK 94919712T DK 0703781 T3 DK0703781 T3 DK 0703781T3
Authority
DK
Denmark
Prior art keywords
efaroxan
disease
derivatives
preparation
drug
Prior art date
Application number
DK94919712T
Other languages
English (en)
Inventor
Francis Colpaert
Michael Briley
Thierry Imbert
Original Assignee
Pf Medicament
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pf Medicament filed Critical Pf Medicament
Application granted granted Critical
Publication of DK0703781T3 publication Critical patent/DK0703781T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
DK94919712T 1993-06-18 1994-06-15 Anvendelse af Efaroxan og derivater deraf til fremstilling af et lægemiddel til behandling af Parkinsons sygdom DK0703781T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9307379A FR2706303B1 (fr) 1993-06-18 1993-06-18 Utilisation de l'Efaroxan et de ses dérivés pour la préparation d'un médicament destiné au traitement de la maladie de Parkinson.
PCT/FR1994/000715 WO1995000145A1 (fr) 1993-06-18 1994-06-15 Utilisation de l'efaroxan et de ses derives pour la preparation d'un medicament destine au traitement de la maladie de parkinson

Publications (1)

Publication Number Publication Date
DK0703781T3 true DK0703781T3 (da) 2000-10-02

Family

ID=9448287

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94919712T DK0703781T3 (da) 1993-06-18 1994-06-15 Anvendelse af Efaroxan og derivater deraf til fremstilling af et lægemiddel til behandling af Parkinsons sygdom

Country Status (15)

Country Link
US (1) US5948806A (da)
EP (1) EP0703781B1 (da)
JP (1) JP3394257B2 (da)
AT (1) ATE192650T1 (da)
AU (1) AU689783B2 (da)
CA (1) CA2165437A1 (da)
DE (1) DE69424415T2 (da)
DK (1) DK0703781T3 (da)
ES (1) ES2147576T3 (da)
FR (1) FR2706303B1 (da)
GR (1) GR3034062T3 (da)
NZ (1) NZ268039A (da)
PT (1) PT703781E (da)
WO (1) WO1995000145A1 (da)
ZA (1) ZA944281B (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6281207B1 (en) * 1999-09-15 2001-08-28 Reed Richter Treatment of movement disorders by administration of mirtazapine
FR2814368B1 (fr) * 2000-09-26 2004-05-07 Pf Medicament Preparation pharmaceutique a base d'oxans
CA2428603C (en) * 2000-11-14 2010-06-22 Orion Corporation Prevention of development of dyskinesias with an alfa 2-adrenoceptor antagonist
US8188126B2 (en) 2002-05-16 2012-05-29 Pierre Fabre Medicament Imidazolic compounds and use thereof as alpha-2 adrenergic receptors
WO2014172372A1 (en) 2013-04-15 2014-10-23 Northwestern University Treatment for dopaminergic disorders

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZW13782A1 (en) * 1981-07-28 1982-10-06 Reckitt & Colmann Prod Ltd Imidazoline derivatives
FR2669030B1 (fr) * 1990-11-14 1992-12-31 Adir Nouveaux derives d'imidazole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
US5281607B1 (en) * 1992-10-08 1998-05-19 Univ New York Method of using alpha 2-antagonists for the treatment of neurodegenerative diseases

Also Published As

Publication number Publication date
DE69424415T2 (de) 2000-12-21
FR2706303B1 (fr) 1995-09-08
ZA944281B (en) 1995-02-10
EP0703781A1 (fr) 1996-04-03
ATE192650T1 (de) 2000-05-15
US5948806A (en) 1999-09-07
AU7076494A (en) 1995-01-17
PT703781E (pt) 2000-10-31
CA2165437A1 (fr) 1994-12-19
DE69424415D1 (de) 2000-06-15
WO1995000145A1 (fr) 1995-01-05
AU689783B2 (en) 1998-04-09
GR3034062T3 (en) 2000-11-30
JPH09500375A (ja) 1997-01-14
NZ268039A (en) 1999-06-29
EP0703781B1 (fr) 2000-05-10
FR2706303A1 (fr) 1994-12-23
JP3394257B2 (ja) 2003-04-07
ES2147576T3 (es) 2000-09-16

Similar Documents

Publication Publication Date Title
ATE205086T1 (de) Verwendung von dem chelatbildner clioquinol zur herstellung eines arzneimittelszur behandlung von alzheimerschen krankheit
DK0869808T3 (da) Anvendelse af Glu-Trp-dipeptider til fremstilling af et lægemiddel til behandling af forskellige tilstande, der involverer neovaskularisation
BG101118A (en) Therapeutical compounds
NO952309D0 (no) Anvendelse av riluzol ved behandling av Parkinsons sykdom og Parkinsonske syndromer
IS1910B (is) Notkun á fankínóni til meðhöndlunar á Alzheimers-sjúkdómi
DK0703781T3 (da) Anvendelse af Efaroxan og derivater deraf til fremstilling af et lægemiddel til behandling af Parkinsons sygdom
ATE183088T1 (de) Arzneimittel zur behandlung von hauterkrankungen
DK0538690T3 (da) Arylquinolyl-substituerede 1,4-dihydropyridin-dicarboxylsyrederivater, fremgangsmåde til deres fremstilling af deres anvendelse i lægemidler
DK0670721T3 (da) Lægemiddel til behandling og forebyggelse af knogle- og ledsygdomme
HUP0004647A2 (hu) Glükóz-amino-glükánok alkalmazása diabétesszel társult szembetegségek kezelésére szolgáló gyógyszerkészítmények előállítására
DK0707477T3 (da) Anvendelse af Efaxoran og derivater deraf til fremstilling af lægemidler beregnet til behandling af neurodegenerative sygdo
FR2818147B1 (fr) Nouvelle application therapeutique d'un derive de la thienyclyclohexylamine
NO953072L (no) Anvendelse av inhibitorer av ornitinaminotransferase for fremstilling av et medikament for behandling av Alzheimers sykdom
ITGE910094A0 (it) Prodotto per la cura e la prevenzione del cancro e dell'aids
BR9714184A (pt) Utilização de bonzoillquil-1,2,3,6-tetraidropiridinas
ZA921101B (en) Use of tetra: Hydro-thieno-pyrido-indole derivatives for the prepartion of a medicine for the treatment of skin disorders.
DK8893D0 (da) Medicament for treatment or prevention of disease